|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 231/02 | |
| C07C 231/14 | |||
| C07C 231/24 | |||
| C07C 237/46 |
| (11) | Patento numeris | 2900632 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13771008.3 |
| Europos patento paraiškos padavimo data | 2013-09-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/060081 |
| Data | 2013-09-17 |
| (87) | Numeris | WO 2014/052091 |
| Data | 2014-04-03 |
| (30) | Numeris | Data | Šalis |
| 20121102 | 2012-09-27 | NO |
| (72) |
THANING, Mikkel, NO
OLSSON, Andreas, NO
GLOGARD, Christian, NO
|
| (73) |
GE HEALTHCARE AS,
Nycoveien 1, 0485 Oslo,
NO
|
| (54) | PREPARATION OF AN INTERMEDIATE COMPOUND OF IOFORMINOL |
| PREPARATION OF AN INTERMEDIATE COMPOUND OF IOFORMINOL |